ℹ️ Compiled from public regulatory records · Last regulator revision: November 19, 2025🚩 Report this page
Magnesium Phosphate
Electrolyte Solutions
Sold as Muscle Ice · AM-5 · Heart Liquescence · Ligatend Liquescence · CALCAREA PHOSPHORICA 6X
US FDA
- Drug class
- Electrolyte Solutions
- Availability
- Over-the-counter
- Routes
- Oral, Sublingual, Topical
- Markets covered
- 1
- Products on record
- 6
- FDA reports (12 mo)
- 83
Overview
Magnesium Phosphate is an active pharmaceutical ingredient in the Electrolyte Solutions group (B05XA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 6 | November 19, 2025 |
USUnited States· FDA
6 products
Uses
** **Claims based on traditional homeopathic principles, not accepted medical evidence. Not FDA evaluated.
How to take
Sources & citations
- [1]FDA DailyMed · 03b6e2a9-f335-4a… · revised June 13, 2024 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.